MAY 20, 2017 10:46 AM PDT

Scientists Exploit Zika to Kill Brain Cancer

WRITTEN BY: Xuan Pham

Zika was a relatively an unknown name in the Americas until around 2015 when the outbreak in Brazil caught the world’s attention. The virus is known to cause severe birth defects in the developing fetus. But while much attention has been devoted to understanding and preventing Zika transmission, researchers at the University of Cambridge see a golden opportunity in Zika as a way to fight against deadly brain cancers.

Image credit: wikipedia.org

“Zika virus infection in babies and children is a major global health concern, and the focus has been to discover more about the virus to find new possible treatments,” said Dr. Harry Bulstrode, a Cancer Research UK scientist at Cambridge. “We’re taking a different approach, and want to use these new insights to see if the virus can be unleashed against one of the hardest to treat cancers.”

In particular, Bulstrode and his team are fascinated by Zika’s ability to cross the blood-brain barrier, an elusive feat that most drugs can’t achieve. Indeed, Johns Hopkins researchers were among the first to prove that the Zika virus is capable of crossing both the placental barrier and the blood-brain barrier. Furthermore, in the brain, the virus targets cortical neural progenitor cells to make more of the virus. This is one of the mechanisms behind the microcephaly birth defects seen in babies born to Zika-infected mothers.

But while the virus wreaks havoc in the developing fetal brain, the virus usually doesn’t do much in the adult brain. And these attributes can be exploited to treat glioblastomas, the most common and deadly form of primary brain cancer.

Bulstrode and his team see the virus as effective glioblastomas killers, as the cancer cells may be similar to the stem cells that the virus attacks in the fetal brain. The potential is huge, and Bulstrode’s team has been awarded with a sizeable grant to test this in cell and animal models. Their goal will be to show whether Zika can selectively target glioblastoma cells without harming nearby healthy tissues.

“We hope to show that the Zika virus can slow down brain tumour growth in tests in the lab.  If we can learn lessons from Zika’s ability to cross the blood-brain barrier and target brain stem cells selectively, we could be holding the key to future treatments,” said Bulstrode.

“We urgently need new insights and treatments to tackle glioblastomas, one of the most common and difficult to treat forms of brain tumours,” said Dr. Iain Foulkes, director of research and innovation at Cancer Research UK. “Finding new ways to treat brain tumours to help more people survive the disease is a priority for Cancer Research UK. Dr Bulstrode’s research is an incredibly innovative way to expand our understanding of how we can beat this disease, which remains a notorious challenge.

Additional source: Cancer Research UK

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 24, 2019
Genetics & Genomics
NOV 24, 2019
22 Genes Discovered that Predict Skin Cancer from Sun Exposure
Australia has the highest rate of skin cancer in the world, with around 49 cases per 100,000 people. Now, researchers at the QIMR Berghofer Medical Researc...
DEC 14, 2019
Cancer
DEC 14, 2019
Common antibiotic could improve radiation therapy
Have you ever taken the antibiotic vancomycin? As a commonly prescribed antibiotic for colitis and infections caused by Clostridium difficile, vancomycin i...
JAN 02, 2020
Cancer
JAN 02, 2020
Early onset stomach cancer in young people
New research from Mayo Clinic published recently in the journal Surgery details a distinction in the types of stomach cancer that affects particularly youn...
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Epigenetic Changes Make Breast Cancer Cells Drug Resistant
Researchers have found that changes in the structure of the genome in breast cancer cells can make them resistant to drug therapies....
JAN 20, 2020
Technology
JAN 20, 2020
Open-Source Software Judges The Accuracy of Cancer Predicting Computer Programs
Cancers are generally composed of diverse cells that vary in genetics—these variations often make a particular cancer more susceptible or resistant t...
FEB 11, 2020
Cancer
FEB 11, 2020
Could we be over-diagnosing cancer?
Roughly one in every two people are estimated to receive a cancer diagnosis at some point in their lives, but are all of those diagnoses valid? New researc...
Loading Comments...